Scott Randal W. bought BBIO
May 15, 2026 · Form 4 insider transaction
Scott Randal W. bought 10,000 shares of BridgeBio Pharma, Inc. at $16.75 per share, a transaction worth $167.5K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
10,000
Price
$16.75
Total value
$167.5K
InsiderScott Randal W.
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 15, 2026
Filing dateMay 19, 2026
Shares owned after21,589
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 27, 2025.